Patents by Inventor Pierre Ducray
Pierre Ducray has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240270729Abstract: The present invention provides compounds of formula (I): which are useful for long-lasting treatment and control of pests, optionally fleas and ticks, in companion animals and livestock, and pharmaceutical compositions and methods of using the same.Type: ApplicationFiled: June 15, 2022Publication date: August 15, 2024Inventors: Pierre Ducray, Denise Rageot, Andreas Turberg
-
Publication number: 20220064159Abstract: The present invention provides compounds of formula (I): which are useful in the control of endoparasites, for example heartworms, in warm-blooded animals.Type: ApplicationFiled: December 13, 2019Publication date: March 3, 2022Inventors: Chouaib Tahtaoui, Denise Rageot, Francois Pautrat, Pierre Ducray
-
Publication number: 20220064160Abstract: The present invention provides compounds of formula (I): which are useful in the control of endoparasites, for example heartworms, in warm-blooded animals.Type: ApplicationFiled: December 13, 2019Publication date: March 3, 2022Inventors: Chouaib Tahtaoui, Denise Rageot, Francois Pautrat, Pierre Ducray
-
Patent number: 10370375Abstract: The invention relates to a compound of formula (I) wherein the variables have the meaning as indicated in the claims; in free form and in salt form; and optionally the enantiomers and geometrical isomers thereof. The compounds of formula (I) are useful as therapeutic agent for organ transplants, lupus, multiple sclerosis, rheumatoid arthritis, psoriasis. Type I diabetes and complications from diabetes, cancer, asthma, atopic dermatitis, autoimmune thyroid disorders, ulcerative colitis, inflammatory bowel diseases, Crohn's disease, Alzheimer's disease, leukemia, osteoarthritis, control of pruritus, chronic respiratory disease or keratoconjunctivitis in mammals.Type: GrantFiled: August 6, 2018Date of Patent: August 6, 2019Assignee: Elanco Tiergesundheit AGInventors: Noelle Gauvry, Chouaib Tahtaoui, Pascal Furet, Pierre Ducray
-
Publication number: 20180346465Abstract: The invention relates to a compound of formula (I) wherein the variables have the meaning as indicated in the claims; in free form and in salt form; and optionally the enantiomers and geometrical isomers thereof. The compounds of formula (I) are useful as therapeutic agent for organ transplants, lupus, multiple sclerosis, rheumatoid arthritis, psoriasis. Type I diabetes and complications from diabetes, cancer, asthma, atopic dermatitis, autoimmune thyroid disorders, ulcerative colitis, inflammatory bowel diseases, Crohn's disease, Alzheimer's disease, leukemia, osteoarthritis, control of pruritus, chronic respiratory disease or keratoconjunctivitis in mammals.Type: ApplicationFiled: August 6, 2018Publication date: December 6, 2018Inventors: Noelle Gauvry, Chouaib Tahtaoui, Pascal Furet, Pierre Ducray
-
Patent number: 10059709Abstract: The invention relates to a compound of formula (I) wherein the variables have the meaning as indicated in the claims; in free form and in salt form; and optionally the enantiomers and geometrical isomers thereof. The compounds of formula (I) are useful as therapeutic agent for organ transplants, lupus, multiple sclerosis, rheumatoid arthritis, psoriasis, Type I diabetes and complications from diabetes, cancer, asthma, atopic dermatitis, autoimmune thyroid disorders, ulcerative colitis, inflammatory bowel diseases, Crohn's disease, Alzheimer's disease, leukemia, osteoarthritis, control of pruritus, chronic respiratory disease or keratoconjunctivitis in mammals.Type: GrantFiled: March 25, 2015Date of Patent: August 28, 2018Assignee: Elanco Tiergesundheit AGInventors: Noelle Gauvry, Chouaib Tahtaoui, Pascal Furet, Pierre Ducray
-
Publication number: 20170050965Abstract: The invention relates to a compound of formula (I) wherein the variables have the meaning as indicated in the claims; in free form and in salt form; and optionally the enantiomers and geometrical isomers thereof. The compounds of formula (I) are useful as therapeutic agent for organ transplants, lupus, multiple sclerosis, rheumatoid arthritis, psoriasis, Type I diabetes and complications from diabetes, cancer, asthma, atopic dermatitis, autoimmune thyroid disorders, ulcerative colitis, inflammatory bowel diseases, Crohn's disease, Alzheimer's disease, leukemia, osteoarthritis, control of pruritus, chronic respiratory disease or keratoconjunctivitis in mammals.Type: ApplicationFiled: March 25, 2015Publication date: February 23, 2017Inventors: Noelle Gauvry, Chouaib Tahtaoui, Pascal Furet, Pierre Ducray
-
Patent number: 8940782Abstract: The present invention is directed to a non-therapeutical process for deterring vermin, which is based on the usage of the largely known beta amino-alcohol derivatives of formula (I) as described herein. Further, the present invention is directed to corresponding vermin-deterring compositions which contain these substances as the active ingredient, compounds of the formula (I) for the preparation of vermin-deterring compositions, and the use of compounds of formula (I) in the defense against vermin.Type: GrantFiled: November 16, 2012Date of Patent: January 27, 2015Assignee: Novartis AGInventors: Pierre Ducray, Tania Cavaliero, Maike Renner, Jacques Bouvier
-
Patent number: 8338490Abstract: The invention describes essentially a non-therapeutical process for deterring vermin, which is based on the usage of the largely known beta amino-alcohol derivatives of formula (I), as defined herein before. Furthermore, it describes the corresponding vermin-deterring compositions which contain these substances as the active ingredient, compounds of the formula (I) for the preparation of vermin-deterring compositions, and the use of compounds of formula (I) in the defense against vermin. Thus, the invention describes how and in which form the compounds of the formula (I) or their acid addition salts are used to deter vermin from materials, places or warm-blooded animals.Type: GrantFiled: November 21, 2007Date of Patent: December 25, 2012Assignee: Novartis AGInventors: Pierre Ducray, Tania Cavaliero, Maike Lohrmann, Jacques Bouvier
-
Patent number: 7964635Abstract: The invention relates to compounds of the general formula (I) wherein X, Y and W have the significances given in claim 1 and optionally the enantiomers thereof. The active ingredients have advantageous pesticidal properties. They are especially suitable for controlling parasites in and on warm-blooded animals.Type: GrantFiled: January 8, 2009Date of Patent: June 21, 2011Assignee: Novartis AGInventors: Noëlle Gauvry, Thomas Goebel, Pierre Ducray, François Pautrat, Ronald Kaminsky, Martin Jung
-
Patent number: 7705044Abstract: The invention relates to compounds of the general formula and optionally the enantiomers thereof. These compounds have advantageous pesticidal properties. They are especially suitable for controlling parasites in warm-blooded animals.Type: GrantFiled: May 14, 2002Date of Patent: April 27, 2010Assignee: Novartis AGInventors: Pierre Ducray, Jacques Bouvier, Matthias Keller, Corina Bergamin
-
Patent number: 7705047Abstract: The invention relates to compounds of the general formula wherein either R signifies C1-C6-alkyl, halo-C1-C6-alkyl, C1-C6-alkoxy-C2-C6-alkyl or halo-C1-C6-alkoxy-halo-C2-C6-alkyl; and X1 signifies a single bond, O, S, S(O) or S(O)2; or R signifies halogen and X1 signifies a single bond; X2 signifies CN, halogen, C1-C6-alkyl, halo-C1-C6-alkyl, C1-C6-alkoxy, halo-C1-C6-alkoxy, C1-C6-alkoxycarbonyl, C1-C6-alkylthio, C1-C6-alkylsulfinyl, C1-C6-alkylsulfonyl, C1-C6-alkylsulfonylamino, halo-C1-C6-alkylsulfonylamino, OH, NH2, COOH, CONH2, C1-C6-alkylaminocarbonyl or C1-C6-alkylcarboxamido, whereby if n is greater than 1, X2 may differ from each other; m signifies 1, 2, 3 or 4; and n is 1, 2, 3, 4 or 5, and optionally the enantiomers thereof. The active ingredients have advantageous pesticidal properties. They are especially suitable for controlling parasites on warm-blooded animals.Type: GrantFiled: December 9, 2004Date of Patent: April 27, 2010Assignee: Novartis AGInventors: Thomas Goebel, Noëlle Gauvry, Pierre Ducray
-
Patent number: 7700656Abstract: The invention relates to the use of aminoacetonitrile compounds of formula (I), wherein R1, R2, R3, R4, R8, R9, A, m and n have the significances given in claim 1, in the control of endoparasites, especially helminths, in warm-blooded productie livestock and domestic animals.Type: GrantFiled: December 18, 2001Date of Patent: April 20, 2010Assignee: Novartis AGInventors: Pierre Ducray, Jacques Bouvier
-
Patent number: 7678383Abstract: The invention relates to aminoacetonitrile compounds of the formula wherein m is 1, 2 or 3; R1 is C1-C4-alkyl, C1-C4-alkoxy, C1-C4-haloalkyl, C1-C4-haloalkoxy or halogen, whereby the substituents may respectively be identical or different, if m is greater than 1; and R2 is C1-C4-haloalkyl; and optionally enantiomers thereof; and the use of aminoacetonitrile compounds of formula I in the control of endoparasites, especially helminths, in warm-blooded productive livestock and domestic animals.Type: GrantFiled: June 14, 2002Date of Patent: March 16, 2010Assignee: Novartis AGInventor: Pierre Ducray
-
Publication number: 20100063090Abstract: The invention describes essentially a non-therapeutical process for deterring vermin, which is based on the usage of the largely known beta amino-alcohol derivatives of formula (I), as defined herein before. Furthermore, it describes the corresponding vermin-deterring compositions which contain these substances as the active ingredient, compounds of the formula (I) for the preparation of vermin-deterring compositions, and the use of compounds of formula (I) in the defense against vermin. Thus, the invention describes how and in which form the compounds of the formula (I) or their acid addition salts are used to deter vermin from materials, places or warm-blooded animals.Type: ApplicationFiled: November 21, 2007Publication date: March 11, 2010Applicant: Novartis AGInventors: Pierre Ducray, Tania Cavaliero, Maike Lohrmann, Jacques Bouvier
-
Patent number: 7642379Abstract: The invention relates to compounds of the general formula (I) wherein Ar, R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, W, a, b, m, n, o and p are as defined in claim 1, and to any enantiomers thereof. The active ingredients have advantageous pesticidal properties. They are particularly suitable for controlling parasites in warm-blooded animals.Type: GrantFiled: June 9, 2005Date of Patent: January 5, 2010Assignee: Novartis AGInventors: Noëlle Gauvry, Pierre Ducray, Thomas Goebel, Ronald Kaminsky
-
Publication number: 20090176868Abstract: The invention relates to compounds of the general formula (I) wherein X, Y and W have the significances given in claim 1 and optionally the enantiomers thereof. The active ingredients have advantageous pesticidal properties. They are especially suitable for controlling parasites in and on warm-blooded animals.Type: ApplicationFiled: January 8, 2009Publication date: July 9, 2009Applicant: Novartis AGInventors: Noelle Gauvry, Thomas Goebel, Pierre Ducray, Francois Pautrat, Ronald Kaminsky, Martin Jung
-
Patent number: 7521476Abstract: The invention relates to compounds of the general formula (I), wherein R1, R2, R3, R4, R5, R6, R7, R8, R8?, R9, W, a, b and n have the significances given in claim 1, and optionally the enantiomers thereof. The active ingredients have advantageous pesticidal properties. They are especially suitable for controlling parasites on warm-blooded animals.Type: GrantFiled: June 18, 2003Date of Patent: April 21, 2009Assignee: Novartis AGInventors: Pierre Ducray, Thomas Goebel
-
Patent number: 7494956Abstract: The invention relates to compounds of the general formula (I) wherein X, Y and W have the significances given in claim 1 and optionally the enantiomers thereof. The active ingredients have advantageous pesticidal properties. They are especially suitable for controlling parasites in and on warm-blooded animals.Type: GrantFiled: November 5, 2004Date of Patent: February 24, 2009Assignee: Novartis AGInventors: Noëlle Gauvry, Thomas Goebel, Pierre Ducray, François Pautrat, Ronald Kaminsky, Martin Jung
-
Patent number: 7485751Abstract: The invention is directed at a new process for the preparation of pure enantiomers from the racemate of amidoacetonitrile compounds of formula wherein R1, R2 and R3, independently of each other, signify hydrogen, halogen, nitro, cyano, C1-C6-alkyl, halogen-C1-C6-alkyl, C1-C6-alkoxy, halogen-C1-C6-alkoxy, C2-C6-alkenyl, halogen-C2-C6-alkenyl, C2-C6-alkinyl, halogen-C2-C6-alkinyl, C2-C6-alkenyloxy, halogen-C2-C6-alkenyloxy, C1-C6-alkylthio, halogen-C1-C6-alkylthio, C1-C6-alkylsulfonyloxy, halogen-C1-C6-alkylsulfonyloxy, C1-C6-alkylsulfinyl, halogen-C1-C6-alkylsulfinyl, C1-C6-alkylsulfonyl, halogen-C1-C6-alkylsulfonyl, C1-C6-alkenylthio, halogen-C1-C6-alkenylthio, C1-C6-alkenylsulfinyl, halogen-C1-C6-alkenylsulfinyl, C1-C6-alkenylsulfonyl, halogen-C1-C6-alkenylsulfonyl, C1-C6-alkylamino, di-(C1-C6-alkyl)amino, C1-C6-alkylaminocarbonyl, di-(C1-C6-alkyl)aminocarbonyl, C1-C6-alkylsulfonylamino, halogen-C1-C6-alkylsulfonylamino, C1-C6-alkylcarbonyl, halogen-C1-C6-alkylcarbonyl, C1-C6-alkoxycarbonyl, unsubstitutType: GrantFiled: November 7, 2005Date of Patent: February 3, 2009Assignee: Novartis Animal Health US, Inc.Inventors: Pierre Ducray, Noelle Gauvry, Thomas Goebel, Francois Pautrat